Also from this source

You just read:

Inspiration Biopharmaceuticals Announces Acceptance of European Marketing Authorization Application for IB1001 for the Treatment of Hemophilia B

News provided by

Inspiration Biopharmaceuticals, Inc.

Oct 03, 2011, 01:00 ET